Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
CANSF
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comPOSITIVO
WILLOW BIOSCIENCES TO PRESENT AT THE EMERGING GROWTH CONFERENCE ON AUGUST 9
President and CEO Dr. Chris Savile to provide business update at event open to all investors SUNNYVALE, Calif., Aug. 2, 2023 /CNW/ - Willow Biosciences Inc. ("Willow") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on…
WILLOW AND KALSEC ADVANCE DEVELOPMENT PROGRAM FOR NEW NATURAL FUNCTIONAL INGREDIENT FOR SAVORY FOODS
Program further validates Willow's technology and focus on commercial execution and aligns with its strategic focus on near term revenue generation KALAMAZOO, Mich. and SUNNYVALE, Calif., July 20, 2023 /CNW/ - Willow Biosciences Inc. ("Wil…
Presenting on the Emerging Growth Conference on June 14 Register Now
Emerging Growth MIAMI, June 13, 2023 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 59th Emerging Growth Conference on June 14, 2023. The Emerging Growth Conference identif…
WILLOW BIOSCIENCES TO PRESENT AT THE EMERGING GROWTH CONFERENCE ON JUNE 14
President and CEO Dr. Chris Savile to provide business update at event open to all investors Willow Biosciences Inc. Logo (CNW Group/Willow Biosciences Inc.) MOUNTAIN VIEW, Calif., June 7, 2023 /PRNewswire/ - Willow Biosciences Inc. ("Will…
WILLOW SIGNS MASTER SERVICES AGREEMENT WITH INNOVATIVE BIOTECH COMPANY TO DEVELOP INGREDIENTS FOR AGE-RELATED DISEASES
Biotech partner recognizes strength of Willow's first in class FutureGrown™ technology platform for producing natural products Further expansion and diversification of Willow's product portfolio with collaboration revenue expected in 2023…
KALSEC AND WILLOW BIOSCIENCES TO DEVELOP NOVEL ENZYME FOR PRODUCTION OF AN ADVANCED BEVERAGE INGREDIENT
Rapid success of first collaboration leads to partnership on high-value specialty ingredient Enzyme development expected to enable commercial-scale production in 2024 KALAMAZOO, Mich. and MOUNTAIN VIEW, Calif., May 23, 2023 /CNW/ - Willow…
WILLOW BIOSCIENCES ANNOUNCES ANNUAL GENERAL AND SPECIAL MEETING VOTING RESULTS
MOUNTAIN VIEW, Calif., May 12, 2023 /CNW/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF) is pleased to announce the voting results from its annual general and special meeting of shareholders held on May 12…
WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2023 RESULTS
Starts off year with significant commercial momentum toward focus on delivering robust year-over-year revenue growth for 2023 Previous steps taken to further optimize Willow's business, focus on near-term revenue generation and reduce cash…
WILLOW ANNOUNCES COMMERCIAL AGREEMENT WITH SANDHILL ONE
Commercial agreement follows the early success on the development phase of the UDCA program with Sandhill One Solid execution on development phases leads to execution of agreement; illustrates company progress against targeted milestones a…
WILLOW ANNOUNCES ROLLOUT OF BioOxi PLATFORM PROVIDING VALUABLE AND EXPEDITED BIOCONVERSION-ENABLED CHEMICAL MANUFACTURING
Complements Company's significant expertise in existing strain engineering and precision fermentation Willow Biosciences Inc. Logo (CNW Group/Willow Biosciences Inc.) Offers commercial partners more rapid product innovation at significantl…
WILLOW BIOSCIENCES ANNOUNCES CHANGES TO BOARD AND MANAGEMENT
Willow Continues its Transition to the Bay Area in California with Management Promotions and a New Board Member MOUNTAIN VIEW, Calif. , March 28, 2023 /CNW/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF),…
WILLOW & SUANFARMA ANNOUNCE COMPLETED DEVELOPMENT AND MANUFACTURING PROCESS FOR CBG AND COMMITMENT TO THE PRODUCTION OF NEW MOLECULES IN A NATURAL WAY
CALGARY, AB and MOUNTAIN VIEW, Calif., March 22, 2023 /CNW/ - WILLOW BIOSCIENCES, (TSX: WLLW) (OTCQB: CANSF) and SUANFARMA today jointly announced that they have, together with SUANFARMA's CIPAN manufacturing site, completed the developmen…
WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2022 FINANCIALS AND OPERATIONS AND FILING OF ITS 2022 AIF
Reports Highest Quarterly and Annual Revenue in Company History with Significant Year-Over-Year Growth Expected for 2023 CALGARY, AB and MOUNTAIN VIEW, Calif., March 21, 2023 /CNW/ - Willow Biosciences Inc. ("Willow") (TSX: WLLW) (OTCQB: C…
WILLOW ANNOUNCES APPOINTMENT OF DR. JIM LALONDE TO BOARD OF DIRECTORS
Dr. Lalonde has pioneered key advancements in enzyme engineering and biocatalysis that has revolutionized chemical production, protein engineering for food and nutrition, as well as drug discovery and development leading to new routes to p…
WILLOW ANNOUNCES FOLLOW-ON ENGAGEMENT FOR NEXT PHASE OF PARTNERED PHARMACEUTICAL PROJECT
Represents early progress against targeted milestones anticipated for 2023 to expand company growth CALGARY, AB and MOUNTAIN VIEW, Calif, Jan. 17, 2023 /CNW/ - Willow Biosciences Inc. ("Willow") (TSX: WLLW) (OTCQB: CANSF), a leading biotec…
WILLOW PROVIDES CORPORATE UPDATES, BUSINESS OUTLOOK AND KEY TARGETED MILESTONES ANTICIPATED FOR 2023 TO EXPAND GROWTH
CALGARY, AB AND MOUNTAIN VIEW, Calif., Dec. 14, 2022 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure…
WILLOW FURTHER OPTIMIZES ITS BUSINESS TO FOCUS ON NEAR-TERM REVENUE GENERATION AND REDUCE CASH BURN
CALGARY, AB and MOUNTAIN VIEW, Calif, Dec. 7, 2022 /PRNewswire/ - Willow Biosciences Inc. ("Willow") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent and su…
KALSEC SIGNS MASTER SERVICES AGREEMENT WITH WILLOW BIOSCIENCES FOR THE DEVELOPMENT AND MANUFACTURE OF FUNCTIONAL FOOD INGREDIENTS USING PRECISION FERMENTATION
KALAMAZOO, Mich. and CALGARY, AB and MOUNTAIN VIEW, Calif., Nov. 8, 2022 /PRNewswire/ - Willow Biosciences Inc. ("Willow") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of p…
WILLOW BIOSCIENCES TO HOST INVESTOR PRESENTATION WEBCAST
CALGARY, AB AND MOUNTAIN VIEW, Calif, Nov. 7, 2022 /CNW/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consist…
WILLOW BIOSCIENCES REPORTS THIRD QUARTER 2022 RESULTS AND ANNOUNCES APPOINTMENT OF DR SEUFER-WASSERTHAL AS PRESIDENT AND CEO
CALGARY, AB AND MOUNTAIN VIEW, CA, Nov. 3, 2022 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, con…
WILLOW BIOSCIENCES ANNOUNCES NEW FUNCTIONAL INGREDIENT ASTAXANTHIN ADDED TO PRODUCT PORTFOLIO
CALGARY, AB and MOUNTAIN VIEW, Calif., Oct. 12, 2022 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure…
CALGARY, AB and MOUNTAIN VIEW, Calif, Aug. 31, 2022 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure,…
WILLOW BIOSCIENCES REPORTS SECOND QUARTER 2022 RESULTS
CALGARY, AB AND MOUNTAIN VIEW, CA, Aug. 15, 2022 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, co…
WILLOW BIOSCIENCES APPOINTS DR. PETER SEUFER-WASSERTHAL AS INTERIM PRESIDENT AND CEO
CALGARY, AB and MOUNTAIN VIEW, Calif. , July 18, 2022 /CNW/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, cons…
WILLOW BIOSCIENCES INCORPORATES INSCRIPTA'S ONYX® PLATFORM TO EXPAND STRAIN ENGINEERING CAPABILITIES AND THROUGHPUT
CALGARY, AB and MOUNTAIN VIEW, Calif., June 6, 2022 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure,…
WILLOW BIOSCIENCES EXPANDS ITS PORTFOLIO WITH A NEW PARTNERED PHARMACEUTICAL PROJECT
CALGARY, AB and MOUNTAIN VIEW, Calif., May 31, 2022 /CNW/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consis…
WILLOW BIOSCIENCES ANNOUNCES ANNUAL GENERAL MEETING VOTING RESULTS
VANCOUVER, BC, May 13, 2022/CNW/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF) is pleased to announce the voting results from its annual general meeting of shareholders held on May 13, 2022 (the "Meeting"…
WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2022 RESULTS
VANCOUVER, BC, May 12, 2022 /CNW/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of high-value molecules traditionally d…
WILLOW BIOSCIENCES ANNOUNCES EXPANSION OF ITS FERMENTATION MANUFACTURING NETWORK AND PROGRESS ON ITS CBG GRAS DETERMINATION
VANCOUVER, BC, May 11, 2022 /CNW/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of high-value molecules traditionally d…
WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND 2021 YEAR END RESULTS, FILING OF ITS 2021 AIF, AND OPERATIONAL UPDATE
VANCOUVER, BC, March 29, 2022 /CNW/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company that develops technology to manufacture pure, consistent and sustainable compounds via ye…
WILLOW BIOSCIENCES TO HOST INVESTOR PRESENTATION WEBCAST
VANCOUVER, BC, Jan. 31, 2022 /CNW/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company that manufactures pure, consistent and sustainable cannabinoids via yeast biosynthesis, to…
WILLOW BIOSCIENCES PUBLISHES THE FIRST PEER REVIEWED ARTICLE DEMONSTRATING THE CLINICAL BENEFIT OF CBG FOR SKINCARE
VANCOUVER, BC, Jan. 19, 2022 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company that manufactures pure, consistent and sustainable cannabinoids via yeast biosynthe…
We Think Willow Biosciences (TSE:WLLW) Needs To Drive Business Growth Carefully
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining exploration companies often lose money for years before finding success with a new treatment or mineral discovery. Having…
Willow Biosciences Reports Third Quarter 2021 Results
VANCOUVER, BC, Nov. 15, 2021 /CNW/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF) has released its financial and operating results for the three and nine months ended September 30, 2021, reporting signific…
Willow Biosciences Announces Commercial Scale Operational Update, CBGA Production Update and Corporate Update
VANCOUVER, BC, Sept. 21, 2021 /CNW/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQX: CANSF), a leading biotechnology company that manufactures ultra-pure, sustainably produced cannabinoids via yeast-based biosynthe…
Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing
Individual and institutional investors as well as advisors are invited to log-on to LifeSciencesInvestorForum.com to view presentations NEW YORK, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced that the pres…